Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
— A drug comeback, new FDA approvals, and a new standard for transplant-ineligible patients
Latest in Oncology/Hematology
Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines
Absence of gut function recovery is the primary reason for extended hospital stays
News, features, and commentary about cancer-related issues
Results of FELIX study supported obecabtagene autoleucel's recent FDA approval
News, features, and commentary about cancer-related issues
Results of FELIX study supported obecabtagene autoleucel's recent FDA approval
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Agency is evaluating the need for further regulatory action
Also from SNO: Encouraging early results with ATM pathway inhibition, sonodynamic therapy
Abemaciclib active in previously treated meningioma, fails to impress in glioblastoma combination
Significant impact on RFS with subtotal resection, and molecular analysis suggests hypoxic effect
Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease
Two-fold increase in PFS with postoperative ivosidenib holds up in placebo-controlled trial
Bobby Mukkamala, MD, was diagnosed with grade 2 glioma after experiencing aphasia at AMA meeting
Meta-analysis shows better PFS, OS with RT-first approach, but issue requires more study
New treatments reshape metastatic and muscle-invasive bladder cancer therapy
News, features, and commentary about cancer-related issues
More research needed on role of local therapy in new era of treatment
New antibody indicated for previously treated, unresectable or metastatic HER2-positive disease
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Time for "long goodbye" to the "burning red devil," say editorialists
